USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
05 Jul 2018 | Global | Market Research
Why Now is The Time for Interoperable Healthcare Solutions?
Synopsis from World Café Discussions Held at Health IT Forum of Medica 2017
Healthcare organizations face numerous challenges in today’s dynamic business environment, be it clinical, non-clinical or operational processes in hospitals. The industry is fundamentally focusing on digital transformational strategies, while increasing its investments in next-generation solutions such as clinical information systems, connected ...
$1,500.00 -
29 Jun 2018 | Global | Technology Research
Organ-on-a-chip Innovations Fueling Drug Screening Applications
Novel Organ-chip Platforms Likely to Transform the Drug Screening Process in the Pharmaceutical Industry
Organ-on-a-chip technology involves the incorporation of microphysiological systems harboring dynamic living 3D organoids, tissue-culture, or cell cultures on a microfluidic platform. The physiologically relevant Organ-chip models offer a better and more precise insight to the possible in vivo effects of drugs in the human body. The flexibility of ...
$4,950.00 -
29 Jun 2018 | Global | Technology Research
Innovations in Pain Management: A Technology Blueprint to Counter Opiod Addiction
Exploring Viable Strategies to Reduce Drug-Device Competitive Initiatives that can Deliver the Right Value of Care for Clinically Safe & Effective Management of Pain Disorders
Over the past several decades drug therapies for clinically safe and effective management of various types of pain, classified as being acute, chronic, breakthrough, nerve, and bone-related have been treated with the use of opioids, NSAIDS, anticonvulsants and antidepressants. However, increasing reliance on their use for prolonged intervals and si...
$4,950.00 -
29 Jun 2018 | North America | Technology Research
Reimagining Healthcare Delivery: Impact of Gamification and Patient Engagement
Using Cutting-edge Digital Technologies to Improve Patient Engagement and Adherence
Healthcare industry has undergone major transformation in the last decade with the incorporation of digital technologies. The changing technological as well as social trends, which focuses more on consumerism of healthcare which includes personalized interventions, making patients more accountable for their healthcare, disease awareness, is aimed t...
$4,950.00 -
29 Jun 2018 | Global | Technology Research
Novel Therapies for Rare and Genetic Diseases
Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy
Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...
$4,950.00 -
27 Jun 2018 | North America | Market Research
Endoscope Reprocessing Systems and Software Solutions Market Assessment, Australia, Forecast to 2022
The Market for Endoscope Reprocessing Solutions Would be Driven by Increasing Procedural Volumes, Coupled with Increased Demand for Newer Installations as Well as Replacements
The market for endoscope reprocessing systems and workflow solutions in Australia was worth A$61.1 million in 2017. It is expected to grow at a robust CAGR of 10.1% to reach a market size of A$98.7 million in 2022. The market is segmented into two broad segments, which are then divided into several sub-segments as mentioned below – • Endosco...
$4,950.00 -
27 Jun 2018 | Global | Market Research
Vision 2025—Healthcare in the Smart Home
Opportunities Lie in the Integration of Big Data, AI, Aging-in-Place, Disease Management, and Wellness to Optimize a Single Consumer Health Platform
Smart homes are no longer an emerging concept. Consumers are not only warming up to the idea but also buying home automation products. Smart speakers seem to be the favorite, with sales jumping from a meager 6 million units in 2016 to a whopping 33.2 million units in 2017. The developing ecosystem of home automation products that each of these curr...
$4,950.00 -
21 Jun 2018 | North America | Market Research
Endoscope Reprocessing Systems and Software Solutions Market Assessment, United States, Forecast to 2022
Despite Reaching Near Saturation, the Market will Grow at Healthy Rate Driven by High Procedural Volume Growth Coupled with Consistently High Replacements and Newer Installations
Endoscope reprocessing systems and workflow solutions was a $526.6 million market in the United States in 2017. It is expected to grow at healthy CAGR of 8.6% to reach $796.4 million in 2022. The market is segmented into two broad segments which are then divided into several sub-segments as mentioned below: • Endoscope reprocessing solutions ...
$4,950.00 -
19 Jun 2018 | North America | Market Research
Assessment of the US Digital Dental Solutions Market, Forecast to 2020
Reducing Treatment Time Coupled with Improving Efficiency will Propel the Market Growth in the US
Dental practices and dental laboratories in the US have recognized the importance of adopting digital dental solutions. Digital dental solutions continue to witness substantial growth and are expected to continue expansion as business models and significant value offerings continue to evolve in tandem with the fast-paced world of connected health. ...
$1,500.00 -
08 Jun 2018 | North America | Market Research
US Cardiac Troponin Diagnostics Market, Forecast to 2021
High Prevalence of Heart Disease Propels Market Growth
Cardiac troponins help to diagnose nearly two-thirds of the patients in the diagnosis Acute Coronary Syndrome (ACS) who are missed out by Echocardiogram (ECG). ECG can detect only one-third of the patients with persistent ST-segment Elevation (STEMI), whereas cardiac troponins can distinguish patients without ST-segment elevation (NSTEACS; non-ST s...
$4,950.00
